Linobo, Rosita D.

HRN: 27-22-61  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2025
CEFTRIAXONE 1G (VIAL)
06/01/2025
06/08/2025
IV
2g
OD
Tbi Severe
Checking Initial Appropriateness 
06/06/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/06/2025
06/13/2025
IV
4.5g
Q6
R/i VAP In Sepsis
Waiting Final Action 
06/06/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/06/2025
06/13/2025
IV
500mg
OD
R/i VAP In Sepsis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: